✦ LIBER ✦

Impact of clinical syndrome acuity on the differential response to two glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET trial

✍ Scribed by Gregg W. Stone; David J. Moliterno; Michel Bertrand; Franz-Joseph Neumann; Howard C. Herrmann; Eric R. Powers; Cindy L. Grines; David J. Cohen; Eric A. Cohen; Marc Cohen; Marion Piedmonte; Pete M. DiBattiste

Book ID: 119543650
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 144 KB
Volume: 39
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(02)80091-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of clinical syndrome acuity on th

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting. The TARGET trial

✍ G.W. Stone; D.J. Moliterno; M. Bertrand 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 33 KB

TCT-472: Impact of Different Glycoprotei

TCT-472: Impact of Different Glycoprotein IIb/IIIa Inhibitors in Patients with Acute Coronary Syndromes and Baseline Chronic Kidney Disease: Analysis From The ACUITY Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Comparison of Bivalirudin Versus Bivalir

Comparison of Bivalirudin Versus Bivalirudin Plus Glycoprotein IIb/IIIa Inhibitor Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Having Percutaneous Intervention for Narrowed Saphenous Vein Aorto-Coronary Grafts (the ACUITY Trial Investigators)

✍ Dinesh Kumar; George Dangas; Roxana Mehran; Ajay Kirtane; Michel Bertrand; Ramin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 152 KB

The Effect of Glycoprotein IIb/IIIa Rece

The Effect of Glycoprotein IIb/IIIa Receptor Inhibitor on the Microcirculation in Patients Undergoing High-Risk Coronary Stenting; A Prospective, Randomized Study

✍ Philip Wong; Scott Harding; Ignacio Inglessis; C. Joon Choi; Darren Walters; Yuc 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 90 KB

Safety and Efficacy of Bivalirudin With

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

✍ Harvey D. White; E. Magnus Ohman; A. Michael Lincoff; Michel E. Bertrand; Antoni 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 571 KB

878-3 Subgroup analysis of the impact of

878-3 Subgroup analysis of the impact of the glycoprotein IIb/IIIa inhibitor abciximab in patients undergoing elective stent placement >2 hours after treatment with a 600 milligram loading dose of clopidogrel: Results from the ISAR REACT trial

✍ Peter B Berger; Adnan Kastrati; Julinda Mehilli; Helmut Schuhlen; Josef Dirschin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 66 KB